Summary unavailable.

Questions

Question 1

What is the general use of antineoplastic agents as described in the text?

View answer and explanation
Question 2

According to the text, what is a primary reason for using antineoplastics in combinations?

View answer and explanation
Question 3

Which class of antineoplastic agents is described as causing cross-linking of DNA and having a cell cycle-nonspecific effect?

View answer and explanation
Question 4

What is the mechanism of action for Antimetabolites like fluorouracil and methotrexate?

View answer and explanation
Question 5

According to the table of antineoplastics, which agent is an example of an Enzyme that works by depleting asparagine?

View answer and explanation
Question 6

What is the effect on the cell cycle of Vinca Alkaloids such as vinblastine and vincristine?

View answer and explanation
Question 7

What are the primary contraindications for the use of antineoplastic agents?

View answer and explanation
Question 8

What is the potential interaction between allopurinol and mercaptopurine?

View answer and explanation
Question 9

When assessing a patient on antineoplastic therapy with a low platelet count, for how long should pressure be applied to venipuncture sites?

View answer and explanation
Question 10

What patient teaching is crucial regarding vaccinations for someone undergoing antineoplastic therapy?

View answer and explanation
Question 11

Which of the following is an example of an Anthracycline that interferes with DNA and RNA synthesis?

View answer and explanation
Question 12

What is the primary mechanism of action for Taxoids like docetaxel and paclitaxel?

View answer and explanation
Question 13

What is a key nursing assessment for a patient on antineoplastic therapy to monitor for bone marrow depression?

View answer and explanation
Question 14

In the event of an IV infiltration during antineoplastic therapy, what is the immediate nursing action?

View answer and explanation
Question 15

What type of personal protective equipment should be worn when preparing antineoplastic agents for injection?

View answer and explanation
Question 16

What advice should be given to a patient on antineoplastics regarding crowds and people with infections?

View answer and explanation
Question 17

A patient on antineoplastic therapy is concerned about hair loss. What is the appropriate nursing action according to the text?

View answer and explanation
Question 18

What is the primary evaluation outcome for a patient with leukemia undergoing antineoplastic therapy?

View answer and explanation
Question 19

Which class of antineoplastic agents, including tamoxifen, alters the hormonal status in sensitive tumors?

View answer and explanation
Question 20

What is the mechanism of action for Podophyllotoxin Derivatives like etoposide?

View answer and explanation
Question 21

A patient on antineoplastic therapy reports fatigue, dyspnea, and orthostatic hypotension. What condition should the nurse monitor for?

View answer and explanation
Question 22

According to the text, what is the effect of antineoplastics on a patient's antibody response and risk of adverse reactions to vaccines?

View answer and explanation
Question 23

Which category of antineoplastic agents has an 'Unknown' effect on the cell cycle according to the provided table?

View answer and explanation
Question 24

What is the recommended patient action when stomatitis or oral ulceration occurs during antineoplastic therapy?

View answer and explanation
Question 25

Why should a patient on antineoplastic therapy be advised about birth control?

View answer and explanation
Question 26

What is the mechanism of action for the antitumor antibiotic bleomycin?

View answer and explanation
Question 27

What potential interaction exists between methotrexate and high doses of NSAIDs?

View answer and explanation
Question 28

Which agent is listed as an example of an Enzyme Inhibitor that inhibits topoisomerase?

View answer and explanation
Question 29

What is the primary purpose of administering allopurinol to a patient on antineoplastic therapy?

View answer and explanation
Question 30

What is the primary action of hormonal agents that are Aromatase Inhibitors, such as anastrozole?

View answer and explanation
Question 31

In which situations should antineoplastic agents be used cautiously according to the 'Precautions' section?

View answer and explanation
Question 32

What is a general, additive interaction mentioned in the text for antineoplastics?

View answer and explanation
Question 33

What should the nurse monitor to assess the nutritional status of a patient on antineoplastic therapy?

View answer and explanation
Question 34

Where should solutions for injection of antineoplastic agents be prepared?

View answer and explanation
Question 35

What is a potential consequence of dosing errors with antineoplastic agents mentioned in the text?

View answer and explanation
Question 36

What should the nurse instruct a patient to report immediately if symptoms of infection occur?

View answer and explanation
Question 37

What is the cell cycle effect for agents in the 'ENZYMES' category, such as asparaginase?

View answer and explanation
Question 38

What patient teaching is required for a patient taking antineoplastics regarding oral hygiene and potential ulceration?

View answer and explanation
Question 39

What is one of the desired evaluation outcomes for a patient with a solid tumor treated with antineoplastics?

View answer and explanation
Question 40

Besides treating cancers, what is another use for some antineoplastic agents like cyclophosphamide and methotrexate?

View answer and explanation
Question 41

What is the recommended fluid intake for a patient experiencing symptoms of gout during antineoplastic therapy?

View answer and explanation
Question 42

Which two agents are listed as examples of Vinca Alkaloids in the mechanism of action table?

View answer and explanation
Question 43

What is the general action of most antineoplastic agents on DNA, immune function, or hormonal status?

View answer and explanation
Question 44

What specific patient teaching is mentioned regarding thrombocytopenia precautions?

View answer and explanation
Question 45

What is the cell cycle effect of antineoplastic agents in the 'TAXOIDS' category?

View answer and explanation
Question 46

What is the instruction for a patient who reports symptoms of gout, such as increased uric acid and joint pain?

View answer and explanation
Question 47

What is the cell cycle specificity for irinotecan, an enzyme inhibitor that inhibits topoisomerase?

View answer and explanation
Question 48

Some antineoplastic agents are available in lipid-based formulations. What is the stated advantage of these formulations?

View answer and explanation
Question 49

What should a nurse assess for to monitor for infection during neutropenia?

View answer and explanation
Question 50

What is the final step of patient teaching mentioned in the 'Patient/Family Teaching' section for antineoplastics?

View answer and explanation

Other chapters

HOW TO USE DAVIS'S DRUG GUIDE FOR NURSESEVIDENCE-BASED PRACTICE AND PHARMACOTHERAPEUTICS: Implications for NursesPHARMACOGENOMICSMEDICATION ERRORS: Improving Practices and Patient SafetyDETECTING AND MANAGING ADVERSE DRUG REACTIONSOVERVIEW OF RISK EVALUATION AND MITIGATION SYSTEMS (REMS)SPECIAL DOSING CONSIDERATIONSTHE CYTOCHROME P450 SYSTEMEDUCATING PATIENTS ABOUT SAFE MEDICATION USEAnti-Alzheimer's agentsAntianemicsAntianginalsAntianxiety agentsAntiarrhythmicsAntiasthmaticsAnticholinergicsAnticoagulantsAnticonvulsantsAntidepressantsAntidiabeticsAntidiarrhealsAntiemeticsAntifungalsAntihistaminesAntihypertensivesAnti-infectivesAntiparkinson agentsAntiplatelet agentsAntipsychoticsAntipyreticsAntirheumaticsAntiulcer agentsAntiviralsBeta blockersBone resorption inhibitorsBronchodilatorsCalcium channel blockersCentral nervous system stimulantsCorticosteroidsDiureticsHormonesImmunosuppressantsLaxativesLipid lowering agentsMinerals/electrolytes/pH modifiersNonopioid analgesicsNonsteroidal anti-inflammatory agentsOpioid analgesicsSedative/hypnoticsSkeletal muscle relaxantsThrombolyticsVaccines/immunizing agentsVitaminsDRUGS APPROVED IN CANADANATURAL/HERBAL PRODUCTSMEDICATION SAFETY TOOLSAppendix A. Recent Drug ApprovalsAppendix E. Administering Medications to ChildrenAppendix G. Pediatric Dosage CalculationsAppendix I. Controlled Substance SchedulesAppendix L. Insulins and Insulin TherapyAppendix M. Canadian and U.S. Pharmaceutical PracticesAppendix N. Routine Pediatric and Adult Immunizations